Create a lasting legacy to fund future research and support programs by donating to The Teal Trust.
Including OCRA in your estate plan is an easy way to commit to funding crucial research for ovarian and related gynecologic cancers now and in the future.
Your lawyer or financial advisor can assist with either creating or adjusting your estate plans.
We recommend that your bequest be designated for unrestricted purposes or be directed to general research because we cannot predict future medical advances or the future of our patient support programs.
FreeWill, a secure online resource that we have partnered with, guides you through the process of making or updating a legally valid will and including a gift to OCRA. The entire process takes less than 20 minutes and is 100% free. This is an easy way to help patients and support survivors well into the future.
FreeWill can also help you easily plan beneficiaries for your non-probate assets (such as an IRA, 401(k), life-insurance policy, or any other assets not included in your will) in one place. You can even designate OCRA as a beneficiary of these kinds of assets if you choose.
Please fill out this form to let us know so we can say thank you and update our records!
Email donations@ocrahope.org or call 212-268-1002 to notify us of your plans or for further information.
OCRA is excited to see the work fueled by our new AI Accelerator Grant resonating with a broad array of audiences. Since the Global Ovarian Cancer Research Consortium announced the inaugural AI Accelerator Grant on February 19, coverage has appeared across health, science, and business media outlets. The $1 million global research award—with an additional … Continued
The Global Ovarian Cancer Research Consortium and its inaugural AI Accelerator Grant have been making waves across health, science, and business media, reflecting widespread interest in what this work could mean for patients. The $1 million global research grant, plus an additional $1 million in compute support from Microsoft’s AI for Good Lab, will fund … Continued
Recognizing Advances in Ovarian Cancer Research and Immunotherapy Ovarian Cancer Research Alliance (OCRA) announced today the winners of two prizes recognizing exceptional accomplishments in ovarian cancer research. David Huntsman, MD, FRCPC, FCCMG, was awarded the 2025 Rosalind Franklin Prize for Excellence in Ovarian Cancer Research for his findings that have profoundly impacted the treatment of … Continued
Get email updates about research news, action alerts, and ways to join the fight.
